Recent developments in the classification and assessment of vasculitis.

Area of Science:

• Rheumatology and Immunology
• Vascular Medicine
• Clinical Trial Design

Background:

• Systemic vasculitides are multisystem diseases involving blood vessel inflammation.
• The exact causes (aetiopathogenesis) remain unknown, leading to descriptive nomenclature and classification based on pathology.
• Standardized classification is crucial for conducting large-scale clinical trials.

Purpose of the Study:

• To address the need for revised classification and diagnostic criteria for systemic vasculitides.
• To harmonize existing classification systems, including the American College of Rheumatology (ACR) 1990 criteria and Chapel Hill Consensus Conference definitions.
• To highlight the importance of accurate assessment tools in clinical trials and practice.

Main Methods:

• Development of an algorithm to harmonize the ACR 1990 criteria and Chapel Hill Consensus Conference definitions.
• Review of existing standardized assessment tools for disease activity and damage.
• Discussion of the need for novel diagnostic criteria and revised classification schemes.

Main Results:

• An algorithm has been developed to harmonize current classification definitions.
• Existing assessment tools are widely used in clinical trials and practice.
• A need for new diagnostic criteria and revised classification remains.

Conclusions:

• Harmonization efforts have been made, but revised classification and de novo diagnostic criteria are still required for systemic vasculitides.
• Accurate and objective assessment tools are critical for effective clinical trials and patient management.
• Ongoing development of next-generation assessment tools is anticipated.